ArticleBMC cancer2025

HACD3 promotes malignant progression of NSCLC by suppressing the MKK7/MAPK10 signaling axis.

Xiaoying Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.